Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections was selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control

被引:109
作者
Schentag, JJ
Hyatt, JM
Carr, JR
Paladino, JA
Birmingham, MC
Zimmer, GS
Cumbo, TJ
机构
[1] Millard Fillmore Hlth Syst, Clin Pharmacokinet Lab, Buffalo, NY 14209 USA
[2] SUNY Buffalo, Sch Pharm, Buffalo, NY 14260 USA
关键词
D O I
10.1086/520287
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We extensively studied the epidemiology and time course of endemic methicillin-resistant Staphylococcus aureus (MRSA) in the Millard Fillmore Hospital, a 600-bed teaching hospital in Buffalo. The changeover from methicillin-susceptible S. aureus to MRSA begins on the first hospital day, when patients are given cefazolin as presurgical prophylaxis. Under selective antibiotic pressure, colonizing flora change within 24 to 48 hours. For patients remaining hospitalized, subsequent courses of third-generation cephalosporins further select and amplify the colonizing MRSA population. Therefore, managing antibiotic selective pressure might be essential. Other strategies include attention to dosing, so that serum concentrations of drug exceed the minimum inhibitory concentration, and antibiotic cycling. Although there are some promising new antibiotics on the horizon, it is necessary to deal with many resistance patterns by using the combined strategies of infection control and antibiotic management.
引用
收藏
页码:1204 / 1214
页数:11
相关论文
共 94 条
  • [1] Sequential parenteral and oral ciprofloxacin regimen versus parenteral therapy for bacteremia: A pharmacoeconomic analysis
    AmodioGroton, M
    Madu, A
    Madu, CN
    Briceland, LL
    Seligman, M
    McMaster, P
    Miller, MH
    [J]. ANNALS OF PHARMACOTHERAPY, 1996, 30 (06) : 596 - 602
  • [2] BALLOW CH, 1992, DIAGN MICR INFEC DIS, V15, pS37
  • [3] ANALYSIS OF A NEW METHOD FOR ASSESSING ACTIVITY OF COMBINATIONS OF ANTIMICROBIALS - AREA UNDER THE BACTERICIDAL ACTIVITY CURVE
    BARRIERE, SL
    ELY, E
    KAPUSNIK, JE
    GAMBERTOGLIO, JG
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 16 (01) : 49 - 59
  • [4] ADDITIONAL DNA IN METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS AND MOLECULAR-CLONING OF MEC-SPECIFIC DNA
    BECK, WD
    BERGERBACHI, B
    KAYSER, FH
    [J]. JOURNAL OF BACTERIOLOGY, 1986, 165 (02) : 373 - 378
  • [5] SHOULD WE VIGOROUSLY TRY TO CONTAIN AND CONTROL METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS
    BOYCE, JM
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1991, 12 (01) : 46 - 54
  • [6] BOYCE JM, 1992, INFECT CONT HOSP EP, V13, P725
  • [7] ANTIBIOTIC STREAMLINING FROM COMBINATION THERAPY TO MONOTHERAPY UTILIZING AN INTERDISCIPLINARY APPROACH
    BRICELAND, LL
    NIGHTINGALE, CH
    QUINTILIANI, R
    COOPER, BW
    SMITH, KS
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (09) : 2019 - 2022
  • [8] BUCHWALD D, 1989, REV INFECT DIS, V11, P619
  • [9] CEFAZOLIN VERSUS CEPHALOTHIN IN BETA-LACTAMASE-PRODUCING STAPHYLOCOCCUS-AUREUS ENDOCARDITIS IN A RABBIT EXPERIMENTAL-MODEL
    CARRIZOSA, J
    KOBASA, WD
    SNEPAR, R
    KAYE, KM
    KAYE, D
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1982, 9 (05) : 387 - 393
  • [10] CASEWELL MW, 1986, J ANTIMICROB CHEMOTH, V18, P1